Douglas Kerr insider trades

Open-market stock purchases and sales by Douglas Kerr, Head of R&D and CMO at Dyne Therapeutics, Inc, from SEC Form 4 filings since Jan 11, 2021.

Recent trades

DateStockTradeValue
Oct 20, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Oct 20, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Sep 8, 2026DYN Dyne Therapeutics, IncSold$24.4K
Sep 4, 2026DYN Dyne Therapeutics, IncSold$91.2K
Aug 13, 2026DYN Dyne Therapeutics, IncSold$40.9K
Jun 16, 2026DYN Dyne Therapeutics, IncSold$16.3K
May 13, 2026DYN Dyne Therapeutics, IncSold$28.7K
Mar 5, 2026DYN Dyne Therapeutics, IncSold$13.5K
Feb 12, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Feb 12, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Dec 5, 2025DYN Dyne Therapeutics, IncSold$18.2K

Companies traded

  • DYN Dyne Therapeutics, Inc: 11 sales, last Oct 20, 2026
  • GBIO Generation Bio Co: 16 sales, last Jan 29, 2024

Get free alerts when Douglas Kerr files a new trade →